Alcon Inc. Ordinary Shares (N:ALC)

Business Focus: N/A

Get the company report for the most recent outlook updated daily

Apr 07, 2024 05:59 pm ET

Alcon Publishes Agenda for 2024 Annual General Meeting

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 8, 2024.

Mar 12, 2024 04:30 am ET

Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon® Family of intraocular lenses (IOLs) in India. Utilizing Alcon’s most advanced IOL material in its 20+ years of IOL innovation, Clareon delivers consistent visual outcomes and exceptional clarity that lasts.°,12-18 Clareon’s clarity is born out of a glistening-free§ IOL material that has among the lowest levels of haze and subsurface nanoglistenings (SSNGs), compared to leading competitor IOLs.†,*,12-

Mar 06, 2024 09:55 am ET

Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’ unmet needs.5¤

Mar 06, 2024 08:00 am ET

Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) have surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.1* Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’ unmet needs.5

Feb 27, 2024 04:30 pm ET

Alcon's Broad Portfolio Delivers Robust Sales and Earnings Growth in FY 2023

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve months ended December 31, 2023. For the fourth quarter of 2023, sales were $2.3 billion, an increase of 8% on a reported basis and 10% on a constant currency basis(1), as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.86 and core diluted earnings per share(2) of $0.70 in the fourth quarter of 2023.

Feb 01, 2024 09:02 am ET

Alcon Canada Launches TOTAL30 Multifocal Contact Lenses for Reusable Lens Patients with Presbyopia

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of TOTAL30® Multifocal in Canada, the first and only monthly Water Gradient multifocal contact lens that feels like nothing – even at day 30.1

Jan 10, 2024 08:31 am ET

Thinking about trading options or stock in TG Therapeutics, Microsoft, Eli Lilly And Co, Chevron, or Alcon?

NEW YORK, Jan. 10, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TGTX, MSFT, LLY, CVX, and ALC.

Jan 09, 2024 04:30 pm ET

Alcon Announces Positive Topline Results From Phase 3 COMET Trials of AR-15512, a Novel Topical Drug Candidate for Dry Eye

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced positive topline results from the two pivotal Phase 3 clinical trials (COMET-2 and COMET-3) evaluating the efficacy and safety of AR-15512, a candidate treatment for the signs and symptoms of dry eye disease (DED).

Jan 05, 2024 08:00 am ET

Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements

Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore" or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has finalized a series of updated commercial arrangements with its...

Dec 27, 2023 09:01 am ET

Alcon to Present at 2024 Annual J.P. Morgan Healthcare Conference

Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2024 J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 3:00 p.m. PST.

Nov 14, 2023 04:30 pm ET

Alcon Reports Third Quarter 2023 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and nine months ended September 30, 2023. For the third quarter of 2023, sales were $2.3 billion, an increase of 8% on a reported basis and 9% on a constant currency basis(1), as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.41 and core diluted earnings per share(2) of $0.66 in the third quarter of 2023.

Nov 08, 2023 09:03 am ET

Alcon Canada Launches Clareon Vivity, its Latest Advancement in Presbyopia Correcting IOLs

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that Clareon® Vivity®, the first and only non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) on Alcon’s most advanced lens platform, is now available in Canada.1-6 Cataracts are the most common cause of vision loss globally.14 However, with options such as Clareon Vivity, surgeons can offer cataract patients a lens designed to provide high-quality vision from distance to functional near with a visual disturbance profile demonstrated to

Oct 30, 2023 09:01 am ET

Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will continue to demonstrate the company’s commitment to Eye Care Professionals and patients by providing connected equipment ecosystems via its digital innovation efforts at the upcoming American Academy of Ophthalmology (AAO) 2023 annual meeting. Ophthalmologists, surgical staff, researchers, and industry leaders will have the opportunity to experience Alcon’s latest digital offerings and participate in additional Alcon events during the conference. Alcon AAO event information and registration i

Oct 10, 2023 08:01 am ET

Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the global launch of TOTAL30® Multifocal, the first and only monthly Water Gradient multifocal contact lens—it feels like nothing even at day 30.1 The lenses have begun to roll out in the United States and in select international markets.

Sep 09, 2023 01:01 am ET

Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity® Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof® IQ Vivity® or AcrySof® IQ Vivity® Toric presbyopia-correcting intraocular lens (PCIOL). Data from more than 900 cataract patients demonstrated sustained clinical performance, high patient satisfaction and reduced dependence upon spectacles (glasses). Evidence al

Sep 06, 2023 04:30 pm ET

Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will present a robust lineup of scientific data at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), happening 8-12 Sept. in Vienna, Austria. Alcon will showcase product updates that deliver patient outcomes and operational efficiencies for ophthalmologists and staff, and host events with surgeons sharing their real-world experiences with Alcon’s innovation, at booth #B201. For every attendee’s badge scanned at the Alcon booth, Alcon will further its

Aug 15, 2023 04:30 pm ET

Alcon Reports Second Quarter 2023 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six months ended June 30, 2023. For the second quarter of 2023, sales were $2.4 billion, an increase of 9% on a reported basis and 12% on a constant currency basis(1), as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.34 and core diluted earnings per share(2) of $0.69 in the second quarter of 2023.

May 22, 2023 04:51 pm ET

Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer

Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has entered into a broad set of agreements with its long-term customer,...

May 22, 2023 01:01 am ET

Alcon Advances Company’s Social Impact Through Global Volunteerism

Working together to make a brilliant impact in the communities where they live and work, thousands of Alcon associates from 57 locations around the world are participating in Alcon in Alcon (AiA), a company-wide volunteering initiative. AiA expands Alcon’s year-round focus on increasing access to quality eye care and is an element of Alcon’s overall social impact and sustainability strategy which focuses on three pillars:

May 09, 2023 04:30 pm ET

Alcon Reports First Quarter 2023 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2023. For the first quarter of 2023, sales were $2.3 billion, an increase of 7% on a reported basis and 11% on a constant currency basis(1), as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.35 and core diluted earnings per share(2) of $0.70 in the first quarter of 2023.

May 06, 2023 03:00 pm ET

New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting taking place in San Diego, CA (May 5-8). The investigator-initiated study** led by J. Morgan Micheletti, M.D., demonstrated that Clareon® and Eyhance* monofocal IOLs provide similar range of vision, including distance and intermediate visual acuity.1

May 05, 2023 04:30 pm ET

Alcon Announces Results of 2023 Annual General Meeting

Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2023 Annual General Meeting (AGM).

May 01, 2023 10:44 am ET

Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will once again have the largest surgical ophthalmic presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2023 Annual Meeting, taking place May 5-8 in San Diego. The company is proud to have the benefits of its innovations featured in more studies than ever in its history.1 Alcon will showcase product updates that drive efficiencies for ophthalmologists and staff, and host events with surgeons sharing their real-world experiences. Alcon ASCRS event information and

Mar 29, 2023 05:59 pm ET

Alcon Publishes Agenda for 2023 Annual General Meeting

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 5, 2023.

Mar 23, 2023 09:05 am ET

Alcon’s “The Lens” Interactive Compliance Training Experience Receives Coveted Anthem Award

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced that its interactive compliance training video experience, The Lens, has been named Best Special Workforce Initiative: Health in the 2nd Annual Anthem Awards. Launched in 2021 by The Webby Awards, The Anthem Award winners are selected by the International Academy of Digital Arts and Sciences.

Mar 20, 2023 08:55 am ET

Alcon to Host 2023 Capital Markets Day

Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2023 Capital Markets Day on March 30, 2023 beginning at 8:00 a.m. CT.

Mar 01, 2023 09:03 am ET

Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will unveil its latest innovations and expansive suite of vision care products at the SECO International meeting in Atlanta, Georgia. Alcon will debut TOTAL30® for Astigmatism, the first and only reusable Water Gradient toric lens on the market,1 now available to Eye Care Professionals (ECPs) across the U.S. In addition to showcasing its latest innovations, Alcon will present its newest clinical data and research findings across its vision care, dry eye, allergy and ocular he

Feb 27, 2023 04:30 pm ET

Alcon Reports Fourth Quarter and Full Year 2022 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve months ended December 31, 2022. For the fourth quarter of 2022, sales were $2.2 billion, an increase of 1% on a reported basis and 7% on a constant currency basis(1), as compared to the same quarter of the previous year. Alcon reported a loss per share of $0.20 and core diluted earnings per share(2) of $0.42 in the fourth quarter of 2022.

Feb 12, 2023 09:05 pm ET

Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices

Alcon Inc. ("Alcon") (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into a settlement agreement with J&J Surgical Vision, Inc. to resolve their pending legal proceedings relating to femtosecond laser assisted cataract surgery devices, including Alcon’s LenSx® device, which Alcon acquired as part of its purchase of LenSx Lasers, Inc. in 2010. As part of the resolution of this matter, the parties have exchanged cross-licenses of certain intellectual property and other mutually agreed covenants and release

Feb 02, 2023 12:27 pm ET

Alcon Canada launches new TOTAL toric lenses for astigmatic patients

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the Canadian launch of TOTAL30® for Astigmatism and DAILIES TOTAL1® for Astigmatism. This launch extends Alcon’s portfolio of reusable and daily disposable lenses, with high-performing options designed for astigmatic patients.

Feb 02, 2023 11:38 am ET

Alcon Canada launches new TOTAL toric lenses for astigmatic patients

Feb 02, 2023 08:01 am ET

Alcon Canada launches new TOTAL toric lenses for astigmatic patients

Jan 05, 2023 01:05 am ET

Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced plans to launch TOTAL30® for Astigmatism, the first-and-only reusable contact lens with Water Gradient material for astigmatic contact lens wearers.

Dec 28, 2022 10:05 am ET

Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference

Alcon (SIX/NYSE: ALC) CEO David Endicott will present at the 2023 J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 11:15 a.m. PST.

Nov 29, 2022 08:30 pm ET

Alcon Prices US$1.3 Billion Senior Notes Offering

Alcon Inc. ("Alcon") (SIX/NYSE: ALC) announced that it has commenced and priced a private offering of US$700 million aggregate principal amount of its 5.375% senior notes due 2032 and US$600 million aggregate principal amount of its 5.750% senior notes due 2052 (together, the “Notes”). The Notes will be issued by Alcon Finance Corporation, Alcon’s indirect subsidiary, and will be fully and unconditionally guaranteed on a senior basis by Alcon.

Nov 22, 2022 01:01 am ET

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”). This transaction helps bolster Alcon’s presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.

Nov 16, 2022 08:31 am ET

Thinking about trading options or stock in Target, NVIDIA, Lowe's Companies, NetEase, or Alcon?

NEW YORK,, Nov. 16, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TGT, NVDA, LOW, NTES, and ALC.

Nov 15, 2022 04:30 pm ET

Alcon Reports Third Quarter 2022 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and nine months ended September 30, 2022. For the third quarter of 2022, sales were $2.1 billion, an increase of 2% on a reported basis and 9% on a constant currency basis(2), as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.23 and core diluted earnings per share of $0.50.

Oct 26, 2022 01:46 pm ET

Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will feature a host of innovations across its broad portfolio of products along with pertinent practice takeaways at the American Academy of Optometry Annual Meeting (#Academy22) in San Diego, California, on October 27, 2022. The meeting coincides with Alcon’s Diamond Jubilee, celebrating 75 years of helping people see brilliantly. Alcon will host an engaging on-site program featuring events and the latest clinical presentations across contact lenses, allergy, dry eye and more.

Sep 29, 2022 09:02 am ET

Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today new product launches in the U.S. as well as activities taking place at the upcoming American Academy of Ophthalmology (AAO) 2022 annual meeting in Chicago.

Sep 27, 2022 02:23 pm ET

AERIE PHARMACEUTICALS - INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. -

NEW ORLEANS, Sept. 27, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Aerie Pharmaceuticals, Inc. (NasdaqGM: AERI) to Alcon Inc. (NYSE: ALC). Under the terms of the proposed transaction, shareholders of Aerie will receive $15.25 in cash for each share of Aerie that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Aug 30, 2022 12:50 pm ET

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Aerie Pharmaceuticals, Inc. (Nasdaq - AERI)

Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Aerie Pharmaceuticals, Inc. (“Aerie” or the “Company”) (Nasdaq – AERI) for possible breaches of fiduciary duty and other violations...

Aug 23, 2022 03:20 pm ET

SHAREHOLDER ALERT: Weiss Law Investigates Aerie Pharmaceuticals, Inc.

NEW YORK, Aug. 23, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") (NASDAQ: AERI), in connection with the proposed acquisition of the Company by Alcon Inc. (NYSE: ALC). Under the terms of the merger agreement, the Company's shareholders will receive $15.25 in cash for each share of Aerie common stock owned. The transaction is valued at approximately $770 million.

Aug 22, 2022 09:18 pm ET

Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, “Aerie”), a pharmaceutical company focused on the discovery, development, manufacturing and commercialization of first-in-class ophthalmic therapies, today announced the companies have entered into a definitive merger agreement through which Alcon will acquire Aerie. This transaction affirms Alcon’s commitment to the ophthalmic pharmaceutical space and is expected to add broader pharmaceutical R&D capabilities to Alcon’s existing commercial expertise,

Aug 09, 2022 04:30 pm ET

Alcon Reports Second Quarter 2022 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six months ended June 30, 2022. For the second quarter of 2022, sales were $2.2 billion, an increase of 5% on a reported basis and 10% on a constant currency basis(2), as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.30 and core diluted earnings per share of $0.63.

Jun 06, 2022 08:00 am ET

Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a partnership with Cooper Kupp, professional football wide receiver and MVP of the “Big Game,” to share his experience with eye allergies and help other eye allergy sufferers find relief with Pataday® Once Daily Relief Extra Strength. This year’s campaign, The Right Tool for the Job, highlights Kupp’s personal struggle to find the right product to treat his eye allergy symptoms and how Pataday has delivered fast-acting, long-lasting, and targete

May 24, 2022 11:50 am ET

Alcon Prices EUR 500.0 Million Senior Notes Offering

Alcon Inc. (SIX/NYSE: ALC), today announced that it has commenced and priced a public offering of EUR 500 million aggregate principal amount of its 2.375% senior notes due 2028 (the “Notes”). The Notes will be issued by Alcon Finance B.V., Alcon Inc.’s indirect wholly-owned subsidiary, and will be fully and unconditionally guaranteed on a senior basis by Alcon Inc.

May 23, 2022 12:01 am ET

Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire EYSUVIS® (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals, Inc.

May 10, 2022 04:30 pm ET

Alcon Reports First Quarter 2022 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the first quarter ended March 31, 2022. For the first quarter of 2022, worldwide sales were $2.2 billion, an increase of 14% on a reported basis and 18% on a constant currency basis(2), as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.34 and core diluted earnings per share of $0.68.

Apr 27, 2022 01:00 pm ET

Alcon Announces Results of 2022 Annual General Meeting

Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2022 Annual General Meeting (AGM).

Apr 23, 2022 08:00 am ET

Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced key data that will be presented at this year’s American Society of Cataract and Refractive Surgery (ASCRS) meeting on its SMART Solutions for cataract surgery. SMARTCataract is the first application in Alcon’s comprehensive cloud-based platform uniquely designed for surgical ophthalmic practices. 2-6 The data shows significant time savings delivered during the cataract evaluation, planning process, operating room (OR) and postoperative (post-op) workflow for cataract pat

Apr 20, 2022 09:00 am ET

Alcon to Deliver Robust Scientific Program at ASCRS 2022

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will once again have a significant scientific presence at the American Society of Cataract and Refractive Surgery (ASCRS) 2022 Annual Meeting, taking place April 22-26 in Washington, D.C. Approximately 150 abstracts feature Alcon’s leading ophthalmic products and equipment—with more than 60 sponsored by Alcon—reinforcing the company’s continued commitment to research and innovation. Registration links for events taking place onsite and booth information is available at

Apr 08, 2022 07:26 pm ET

Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced a partnership with actress Kate Walsh, best known for her roles in Grey’s Anatomy and Emily in Paris, to share her journey with dry eye around the launch of its Systane® Complete Preservative-Free Lubricant Eye Drops. As part of the new Make Every Look Count campaign, Walsh will provide her personal testimonial about how her dry eye symptoms have impacted important moments – on- and off-screen – and how finding real relief with Systane has helped

Apr 07, 2022 09:35 am ET

Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count

Mar 24, 2022 12:05 am ET

Alcon Publishes Agenda for 2022 Annual General Meeting

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 27, 2022.

Mar 07, 2022 01:00 am ET

Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon® family of intraocular lenses (IOLs) in the U.S. Utilizing Alcon’s most advanced IOL material, Clareon can deliver consistent visual outcomes and exceptional clarity that lasts.°,1-7 The Clareon clarity is born out of a glistening-free§ IOL material that has among the lowest levels of haze and subsurface nanoglistenings (SSNGs) compared to leading competitor IOLs.†,*,1-3

Feb 15, 2022 04:30 pm ET

Alcon Reports Fourth Quarter and Full Year 2021 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter of 2021, worldwide sales were $2.1 billion, an increase of 11% on a reported basis and 13% on a constant currency basis(2), as compared to the same quarter of the previous year. Fourth quarter 2021 diluted earnings per share were $0.28 and core diluted earnings per share were $0.56. Full year 2021 diluted earnings per share were $0.76 and core diluted earnings per share were $2.15.

Jan 12, 2022 01:00 am ET

Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the European launch of the newest addition to its innovative portfolio of dry eye products – Systane® Complete Preservative-Free Lubricant Eye Drops, now in an easy-to-use, multi-dose bottle.

Jan 11, 2022 01:00 am ET

Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the launch of DAILIES TOTAL1® for Astigmatism, the first and only Water Gradient contact lens for patients with astigmatism. The lenses will be available in the U.S. beginning in March.

Jan 10, 2022 01:00 am ET

Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the closing of its previously announced acquisition of Ivantis®, developer of the novel Hydrus® Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower eye pressure for open-angle glaucoma patients in connection with cataract surgery.*

Nov 09, 2021 04:30 pm ET

Alcon Reports Third Quarter 2021 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and nine months ended September 30, 2021. For the third quarter of 2021, worldwide sales were $2.1 billion, an increase of 15% on a reported basis and 14% on a constant currency basis(2), as compared to the same quarter of the previous year. Third quarter 2021 diluted earnings per share were $0.00 and core diluted earnings per share were $0.54.

Nov 08, 2021 09:00 am ET

Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will feature its latest advancement in integrated and connected surgical technologies – SMART Solutions by Alcon, a digital platform uniquely designed for ophthalmology – at the upcoming American Academy of Ophthalmology (AAO) 2021 annual meeting. This new platform furthers Alcon’s leadership in clinic-to-operating room (OR) integration with image-guided technologies and cloud-based planning. Key data on leading surgical equipment, ARGOS® Biometer with Image Guidance and Optiwave Refrac

Nov 08, 2021 12:59 am ET

Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire Ivantis®, developer and manufacturer of the novel Hydrus® Microstent, a minimally-invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure for open-angle glaucoma patients in connection with cataract surgery*. The intended acquisition affirms Alcon’s commitment to the surgical glaucoma space, further strengthening its industry-leading portfolio across cataract, refractive, retina and glaucoma.

Nov 01, 2021 02:31 pm ET

Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will showcase leading innovations and clinical research findings at the American Academy of Optometry Annual Meeting (#Academy21) in Boston, Massachusetts, from November 3-6, 2021. The meeting will mark the official launch of TOTAL30®, the first-and-only monthly replacement Water Gradient contact lens that feels like nothing even on day 30,1 to the professional eye care community. Alcon’s engaging on-site program will feature events and more than

Oct 14, 2021 09:00 am ET

Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today celebrates World Sight Day 2021 by taking action in communities across the globe to raise awareness of blindness and vision impairment as global public health issues. Celebrated annually in October, World Sight Day is coord

Sep 27, 2021 10:58 am ET

Alcon Honored with FutureEdge 50 Award

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has been recognized as a recipient of the FutureEdge 50 Award from International Data Group (IDG). This prestigious award is bestowed upon organizations for pushing the edge with innovative technologies to advance their business for the future.

Aug 18, 2021 09:31 am ET

Thinking about trading options or stock in Alcon, Daqo New Energy, Lowe's, Tesla, or Plug Power?

NEW YORK, Aug. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALC, DQ, LOW, TSLA, and PLUG.

Aug 17, 2021 04:30 pm ET

Alcon Reports Second Quarter 2021 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and six months ended June 30, 2021. For the second quarter of 2021, worldwide sales were $2.1 billion, an increase of 75% on a reported basis and 69% on a constant currency basis(2), as compared to the same quarter of the previous year. Second quarter 2021 diluted earnings per share were $0.31 and core diluted earnings per share were $0.56.

Aug 11, 2021 01:00 am ET

Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced plans to launch TOTAL30®, the first-and-only monthly replacement, Water Gradient lens that feels like nothing, even on day 30.1 Using Alcon’s proprietary Water Gradient material first introduced with DAILIES TOTAL1® contact lenses, TOTAL30 delivers a premium wearing experience for reusable contact lens wearers. Reusable lenses account for an estimated 45% of the $9 billion global contact lens market.2

Jul 22, 2021 04:35 pm ET

Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people See Brilliantly, will present a breadth of data during the American Society of Cataract and Refractive Surgery (ASCRS) 2021 annual meeting, taking place July 23-27 in Las Vegas. More than 60 abstracts featuring Alcon ophthalmic products and equipment will be presented, reinforcing the Company’s industry-leading portfolio. The full abstract book, registration links for events taking place onsite and booth information is available at

Jun 28, 2021 12:00 pm ET

Alcon Announces Executive Committee Changes

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced changes to its Executive Committee of Alcon (ECA). Changes take effect September 1, 2021.

Jun 09, 2021 04:01 pm ET

Arcutis Announces Appointment of Sue-Jean Lin to Board of Directors

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today...

Jun 07, 2021 04:45 pm ET

Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will present new data on several of its latest innovations at the British Contact Lens Association (BCLA) 2021 Clinical Conference & Exhibition. Among the 18 Alcon abstracts accepted are data on TOTAL30®, which will be the first and only monthly replacement water gradient contact lens.

May 04, 2021 04:30 pm ET

Alcon Reports First Quarter 2021 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2021. For the first quarter of 2021, worldwide sales were $1.9 billion, an increase of 5% on a reported basis and 2% on a constant currency basis(2), as compared to the same quarter of the previous year. First quarter 2021 diluted earnings per share were $0.17 and core diluted earnings per share were $0.49.

Apr 28, 2021 05:17 pm ET

Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire exclusive U.S. commercialization rights to Simbrinza®(brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% from Novartis.

Apr 28, 2021 11:30 am ET

Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting

Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the results of its 2021 Annual General Meeting.

Apr 28, 2021 09:30 am ET

Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of the newest addition to its innovative portfolio of dry eye products – Systane® Hydration Multi-Dose Preservative-Free (MDPF) Lubricant Eye Drops. With its proprietary HydroBoost® Technology, this new preservative-free eye drop provides extra moisture for patients with sensitive dry eyes.

Mar 24, 2021 06:59 pm ET

Alcon Publishes Agenda for Annual General Meeting

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on April 28, 2021.

Mar 12, 2021 04:04 pm ET

Alcon to Host Virtual Capital Markets Day on March 24

Alcon (SIX/NYSE: ALC), the global leader in eye care, will host a virtual Capital Markets Day for the financial and investment community on March 24, 2021. The virtual event will feature presentations from company leaders outlining the company’s strategy and innovation agenda designed to drive long-term growth and improve eye care outcomes for doctors, patients and customers.

Mar 01, 2021 11:00 am ET

Alcon’s Sue-Jean Lin Wins 2021 Dallas CIO of the Year

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, congratulates Sue-Jean Lin, Alcon Senior Vice President and CIO, on her achievement being recognized as the 2021 Dallas CIO of the Year ORBIE Awards winner in the Super Global category. The prestigious CIO of the Year ORBIE Award is a leading technology executive recognition program celebrating those who have demonstrated excellence in technology leadership.

Feb 23, 2021 04:20 pm ET

Alcon Reports Fourth Quarter and Full Year 2020 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the fourth quarter and full year ended December 31, 2020. For the fourth quarter of 2020, worldwide sales were $1.9 billion, an increase of 2% on a reported basis and an increase of 1% on a constant currency basis(2), as compared to the same quarter of the previous year. Fourth quarter 2020 diluted earnings per share were $0.19 and core diluted earnings per share were $0.41. Full year 2020 diluted losses per share were $1.09 and core diluted earnings per share were $1.04.

Feb 18, 2021 08:03 am ET

Alcon Announces Broad Retail Availability of Pataday Once Daily Relief Extra Strength in the U.S.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Pataday® Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%) is now available in-store and online at U.S. retailers, following its 2020 approval by the Food and Drug Administration (FDA) for sale over-the-counter (OTC). As Alcon’s third Rx-to-OTC switch in the past twelve months, Pataday Once Daily Relief Extra Strength joins the #1 selling OTC eye allergy relief brand and is poised to help the company maintain its leadership

Jan 20, 2021 01:00 am ET

Alcon Launches PRECISION1 for Astigmatism Contact Lenses in the U.S.

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced the U.S. launch of PRECISION1® for Astigmatism, a daily disposable, silicone hydrogel (SiHy) contact lens designed for astigmatic patients.

Nov 10, 2020 04:30 pm ET

Alcon Reports Third Quarter 2020 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the third quarter and nine months ended September 30, 2020. For the third quarter of 2020, worldwide sales were $1.8 billion, a decrease of 1% on a reported and constant currency basis(2), as compared to the same quarter of the previous year. Third quarter 2020 diluted losses per share were $0.30 and core diluted earnings per share were $0.39.

Nov 05, 2020 08:00 am ET

Alcon U.S. PRECISION1 Launch Momentum Bolstered by Strong Programs, Differentiated On-Eye Performance

Alcon (SIX/NYSE: ALC), the global leader in eye care, announced continued momentum of its PRECISION1® one-day, silicone hydrogel (SiHy) contact lenses following strong reception by the U.S. Eye Care Professional (ECP) community around its launch in late 2019. Alcon is energizing doctors and patients with data affirming the superior wearing experience of the lens, as well as the See What Happens consumer campaign, featuring actress Katherine McNamara and the PRECISION1 SEE FREE incentive program designed to drive patient awareness and trials during COVID-19 recovery.

Oct 08, 2020 08:00 am ET

Alcon Celebrates World Sight Day 2020 and Continues Commitment to Improving Worldwide Access to Eye Care

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today celebrates World Sight Day through its corporate giving and company-led initiatives focused on improving access to quality eye care. In the spirit of this year’s theme, “Hope in Sight,” Alcon associates will help spark donations to global nonprofit organizations that advance eye health. The goal is to support people around the world in need of eye care, particularly as eye health issues, including vision loss, myopia, cataracts, refractive errors and more, have emerged or worsened due to the

Oct 06, 2020 08:15 am ET

Alcon to Showcase Innovations at #Academy20 that Support Recovery and Growth for Eye Care Practices

Alcon, the global leader in eye care, will highlight leading innovations and clinical research at the 2020 American Academy of Optometry (the Academy or #Academy20) meeting taking place virtually from October 7 – 22, 2020. The company’s robust virtual program will feature updates on its most important innovations, including PRECISION1® one-day contact lenses, Systane® iLux® MGD Treatment System and digital platform MARLO, as well as 23 scientific presentations on a range of technologies.

Aug 20, 2020 08:00 am ET

Alcon and Actress Katherine McNamara Encourage Consumers to See What Happens with PRECISION1® Contact Lenses

Alcon, the global leader in eye care, is teaming up with actress Katherine McNamara on a new direct-to-consumer (DTC) campaign that encourages people to See What Happens when they experience lens freedom with PRECISION1® one-day contact lenses. The campaign highlights how key features of Alcon’s latest contact lens innovation – precise vision, dependable comfort and easy handling1 – can help “Gen-Zennials” in their 20s see the most in every moment of their lives.

Aug 18, 2020 04:30 pm ET

Alcon Reports Second Quarter 2020 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the second quarter and first half ended June 30, 2020. For the second quarter of 2020, worldwide sales were $1.2 billion, a decrease of 36% on a reported basis and a decrease of 34% on a constant currency basis(2), as compared to the same quarter of the previous year. Second quarter 2020 diluted losses per share were $0.86 and core diluted losses per share were $0.21.

Jul 21, 2020 09:00 am ET

Alcon Survey Shows More Screen Time Causing Consumer Concern About Eye Health, Increasing Symptoms of Dry Eye

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the results of a new survey, rolled out in recognition of Dry Eye Awareness Month. The survey, conducted by research firm Ipsos among 1,005 nationally representative U.S. adults, uncovers the impact the COVID-19 pandemic is having on consumers’ screen time and how that impacts their perceptions on eye health. Key findings include:

Jul 17, 2020 09:00 am ET

Alcon to Showcase Latest Innovations, Data at American Society of Retina Specialists 2020 Virtual Annual Meeting

Alcon, the global leader in eye care dedicated to helping people see brilliantly, will present key data highlighting advancements in vitreoretinal surgery during the American Society of Retina Specialists (ASRS) 2020 virtual annual meeting, taking place July 24-26. New data about the effectiveness of the HYPERVIT® Dual Blade Vitrectomy Probe and other retina surgical platforms will be presented. The company will also host a virtual exhibit booth, complete with information on product innovations including latest updates to the NGENUITY® 3D Visualization System (NGENUITY 1.

Jul 15, 2020 09:00 am ET

Alcon Issues First Corporate Responsibility Report as Independent Company

Alcon (SIX/NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, today released its inaugural Corporate Responsibility (CR) report. The CR report, the Company’s first as an independent, publicly traded company, describes Alcon’s corporate responsibility stra

Jul 14, 2020 07:50 am ET

Alcon Announces FDA Approval of the OTC Switch of Pataday Once Daily Relief Extra Strength

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced Pataday Once Daily Relief Extra Strength (olopatadine hydrochloride ophthalmic solution 0.7%), formerly prescribed as Pazeo®, has been approved by the Food and Drug Administration (FDA) for sale over-the-counter (OTC) in the United States. Pataday Once Daily Relief Extra Strength is the first and only once daily eye allergy itch drop offering a full 24 hours of relief without a prescription.1 Allergies are the sixth-leading cause of chroni

May 18, 2020 04:30 pm ET

Alcon Prices US$750.0 Million Senior Notes Offering

Alcon (SIX/NYSE: ALC) announced that it has commenced and priced a private offering of US$750.0 million aggregate principal amount of its 2.600% senior notes due 2030 (the “Notes”). The Notes will be issued by Alcon Finance Corporation, Alcon’s indirect subsidiary, and will be fully and unconditionally guaranteed on a senior basis by Alcon.

May 12, 2020 04:30 pm ET

Alcon Reports First Quarter 2020 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2020. For the first quarter of 2020, worldwide sales were $1.8 billion, an increase of 3% on a reported basis and an increase of 4% on a constant currency basis(2), as compared to the same quarter of the previous year. First quarter 2020 diluted losses per share were $0.12 and core diluted earnings per share were $0.45.

May 11, 2020 01:30 pm ET

Alcon to Highlight Robust Scientific Program Showcasing Latest Innovations at Virtual American Society of Cataract and Refractive Surgery 2020 Annual Meeting

Alcon, the global leader in eye care dedicated to helping people see brilliantly, will present data that further supports advancements in cataract surgery during the virtual American Society of Cataract and Refractive Surgery (ASCRS) 2020 annual meeting, taking place May 16-17. The company will also host a virtual exhibit booth that will provide information on its latest product innovations, including the AcrySof® IQ PanOptix® and ARGOS® Biometer with Image Guidance, educational events and resources for navigating the COVID-19 pandemic.

May 06, 2020 01:00 pm ET

Alcon Shareholders Approve All Proposed Resolutions at the 2020 Annual General Meeting

Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced shareholder approval of all resolutions proposed at its 2020 Annual General Meeting.

Apr 07, 2020 01:00 am ET

Alcon Provides Update on COVID-19

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced a series of updates stemming from the impact of COVID-19.

Mar 12, 2020 02:00 am ET

Alcon Announces European Launch of Vivity, the Only Presbyopia-correcting Intraocular Lens With X-WAVE Technology

Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available in select European markets, with additional countries to follow throughout 2020.

Mar 11, 2020 09:00 am ET

Alcon Partners with Actress Cheryl Ladd to Share Her Cataract Journey, Renewed Vision and PanOptimist Story

Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care, today announced a partnership with actress Cheryl Ladd, best known from the iconic hit TV series Charlie’s Angels, who recently underwent cataract surgery and received the AcrySof® IQ PanOptix® Lens. Cheryl will be sharing her story through a national campaign — “I’m a PanOptimist” — and hopes to inspire people with cataracts, the most common age-related eye condition,2 to take charge of their diagnosis, understand their treatment options and reclaim their optimism for life in all its color.

Feb 25, 2020 04:30 pm ET

Alcon Reports Full Year 2019 Results

Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care, reported its financial results for the full year ended December 31, 2019. Full year worldwide net sales of $7.4 billion, increased 3%, or 5% on a constant currency(2) basis, compared to the full year ended December 31, 2018. Full year 2019 diluted losses per share were $1.34, primarily as a result of non-cash amortization of certain intangibles. Full year core earnings per share were $1.89, driven by core operating income growth of 4%, or 11% on a constant currency basis.

Feb 17, 2020 08:00 am ET

Alcon to Launch Pataday, the Eye Allergy Drop with the #1 Doctor-Prescribed Active Ingredient, following FDA Approval of OTC Switch

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Pataday Once Daily Relief® (olopatadine hydrochloride ophthalmic solution 0.2%) and Pataday Twice Daily Relief® (olopatadine hydrochloride ophthalmic solution 0.1%) have been approved by the Food and Drug Administration (FDA) for sale over the counter (OTC) in the U.S.1,2 The Pataday brand features the No. 1 doctor-prescribed eye allergy itch relief ingredient, and includes the first once daily allergy itch relief drop to be available without a prescri

Nov 19, 2019 04:30 pm ET

Alcon Reports Third Quarter and Nine Months 2019 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the third quarter and nine months ended September 30, 2019.

Nov 06, 2019 07:01 pm ET

Alcon to Announce Third Quarter 2019 Results

Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today that it will report third quarter 2019 results and host a conference call on Wednesday, November 20, at 2:00 p.m. Central European Time / 8:00 a.m. Eastern Time for the quarter ended September 30, 2019. A news release including financial results will be issued on Tuesday, November 19, at 10:30 p.m. Central European Time / 4:30 p.m. Eastern time and will be available at

Oct 21, 2019 09:00 am ET

Alcon Contact Lens and Cataract Innovations to Headline Clinical and Educational Program at #Academy19

Alcon, the global leader in eye care and official sponsor of 20/20™, will bring major contact lens and cataract innovations together for the first time at the 2019 American Academy of Optometry (AAO / #Academy19) meeting taking place October 23-27 at the Orange County Convention Center (OCCC) in Orlando, Fla. Innovations like the newly launched PRECISION1® daily disposable contact lenses, AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), and the iLUX® MGD Treatment System will be included in nearly 20 lectures, podium and poster presentations du

Oct 09, 2019 08:51 am ET

Alcon to Highlight AcrySof IQ PanOptix Trifocal IOL Launch and Groundbreaking IOL Data at American Academy of Ophthalmology Annual Meeting

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its plans to lead a wide-range of informational and peer-to-peer educational programs at the American Academy of Ophthalmology (AAO) Annual Meeting on October 12-15 in San Francisco, CA. The newly launched AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), along with findings from the AAO IRIS® (Intelligent Research in Sight) Registry, will be part of the scientific program.

Sep 16, 2019 11:28 pm ET

Alcon Prices US$2.0 Billion Senior Notes Offering

Alcon (SIX/NYSE: ALC) announced that it has priced a private offering of US$500.0 million aggregate principal amount of its 2.75% senior notes due 2026, US$1.0 billion aggregate principal amount of its 3.0% senior notes due 2029 and US$500.0 million aggregate principal amount of its 3.8% senior notes due 2049 (the “Notes”). The Notes will be issued by Alcon Finance Corporation, Alcon’s indirect subsidiary, and will be fully and unconditionally guaranteed on a senior basis by Alcon.

Aug 27, 2019 01:00 am ET

Alcon Introduces AcrySof IQ PanOptix Trifocal IOL in the U.S., the First and Only FDA-Approved Trifocal Lens

Alcon (SIX/NYSE:ALC), the global leader in eye care, today announced the Food and Drug Administration (FDA) approval and its initial commercial launch of AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery. PanOptix is clinically shown to deliver an exceptional combination of near, intermediate and distance vision while significantly reducing the need for glasses after surgery.1,2

Aug 20, 2019 04:30 pm ET

Alcon Reports Second Quarter and First Half 2019 Results

Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the second quarter and first half ended June 30, 2019.

Aug 19, 2019 01:00 am ET

Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline

Alcon, the global leader in eye care, today announced plans to launch the newest addition to its robust contact lens portfolio – PRECISION1® daily disposable, silicone hydrogel (SiHy) contact lenses – in the U.S. PRECISION1 is the first-and-only contact lens with Alcon’s proprietary SMARTSURFACE® technology – a permanent, micro-thin, high-performance layer of moisture at the lens surface that helps support a stable tear film to deliver lasting visual performance from morning to night.1,2

Jul 16, 2019 09:00 am ET

Alcon to Announce Second Quarter 2019 Results

Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today that it will report second quarter 2019 results and host a conference call on Wednesday, August 21, at 2:00 p.m. Central European Summer Time / 8:00 a.m. Eastern Time for the quarter ended June 30, 2019. A news release including financial results will be issued on Tuesday, August 20, at 10:30 p.m. Central European Summer Time / 4:30 p.m. Eastern Time and will be available at

Jul 11, 2019 07:05 am ET

Alcon Kicks off SYSTANE® Campaign With Businesswoman Barbara Corcoran, Bringing Real Relief to Female Entrepreneurs

Alcon, the global leader in eye care, is kicking off a new program from SYSTANE® aimed at funding women entrepreneurs and their business ideas. Launched in partnership with iFundWomen, a crowdfunding platform designed for female entrepreneurs, Real Relief for Visionary Women will give applicants an opportunity to be considered for fin

Jun 24, 2019 09:15 am ET

New Alcon DAILIES® COLORS Contact Lenses Give Beauty Lovers Permission to Play with Their Eye Color Every Day

Alcon, the global leader in eye care, today announced the debut of DAILIES® COLORS contact lenses that combine the beauty of eye color enhancement with the convenience of a daily disposable contact lens. The new line features four colors – Mystic Blue, Mystic Gray, Mystic Hazel and Mystic Green* – introduced at a time when color contact lenses are re-emerging as an easy and creative way to express personal style. DAILIES® COLORS contact lenses are designed to make eyes look bigger and brighter, and are a new tool in the bea

Jun 19, 2019 01:05 pm ET

Alcon Takes Center Stage with Contact Lens Innovations and the iLUX® System at the 2019 Optometry’s Meeting

Alcon, the global leader in eye care, will launch DAILIES® COLORS contact lenses at the 2019 Optometry’s Meeting, as well as give attendees a preview of PRECISION1™ contact lenses coming soon to the US. These innovations, together with updates on the iLUX® MGD Treatment System, new clinical data and practice insights, will be featured at various Alcon-sponsored events and presentations throughout the meeting. The meeting is taking place June 19-23 at the America’s Center Convention Complex (ACCC) in St. Louis, Missouri.

Jun 18, 2019 09:00 am ET

Gymnast Laurie Hernandez and Alcon Help People See Their Potential with New “Eye Can, Eye Will” Campaign

Alcon, the global leader in eye care, is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on a new campaign that encourages people to find inspiration to visualize and achieve their goals. The “Eye Can, Eye Will” campaign is based on Laurie’s belief that personal mantras and clear, comfortable vision with DAILIES TOTAL1® contact lenses have helped her maintain the focus and enthusiasm needed to get to the top of her game. This campaign is rolling out during a pivotal time for Laurie, as she prepares to compete i

May 15, 2019 05:20 pm ET

Alcon Reports First Quarter 2019 Trading Update

Alcon (SIX:ALC) (NYSE:ALC), the global leader in eye care, today reported selected financial results for the first quarter ending March 31, 2019, and provided financial guidance for the current fiscal year. For the first quarter of 2019, worldwide net sales were $1.8 billion, flat on a reported basis and an increase of 4 percent on a constant currency basis1, as compared to the same quarter of the previous year.

May 01, 2019 09:00 am ET

Alcon to Showcase New Clinical Data, Innovative Technology at American Society of Cataract and Refractive Surgery 2019 Annual Meeting

Alcon, the global leader in eye care dedicated to helping people see brilliantly, will feature new clinical data along with innovative product designs and technology for the Cataract Refractive Suite during the American Society of Cataract and Refractive Surgery (ASCRS) 2019 annual meeting, taking place May 3-7 in San Diego, CA. The company – which recently became an independent, publicly-traded entity – will be included in 170 scientific abstracts at the meeting, underscoring its efforts to support surgeons with the most complete line of

Apr 25, 2019 04:00 pm ET

Alcon to Participate in Bank of America Merrill Lynch and Jefferies Healthcare Conferences

Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it will participate in the following conferences:

Apr 23, 2019 09:00 am ET

Alcon to Host Trading Update for First Quarter 2019 Results

Alcon (SIX: ALC) (NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today that it will provide a trading update and host a conference call on Thursday, May 16, at 3:00 p.m. Central European Time / 8 a.m. Central Time for the quarter ended March 31, 2019. A news release including select financial results will be issued in advance of the call and will be available at

Apr 09, 2019 12:30 am ET

Alcon Debuts as Independent, Publicly Traded Company

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced its debut as an independent, publicly traded company and the completion of its separation from Novartis. The company’s shares begin trading today on the SIX Swiss Exchange and New York Stock Exchange (NYSE) under the symbol “ALC.”

Ad blocking detected

Alcon Inc. Ordinary Shares (N:ALC)

Business Focus: N/A